Top Markets
#1 Purr Purr +56.55%
#2 Pons Pons +53.28%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 StonkBroker StonkBroker +30.71%
#5 Non-Playable Coin Non-Playable Coin +28.02%
#6 TENDIES TENDIES +26.79%
#7 Kinetiq Kinetiq +26.27%
#8 ApeX ApeX +25.71%
#9 Morpho Morpho +22.27%
#10 OriginTrail OriginTrail +21.30%
Coin of the day
Purr Purr
設定
言語
日本
通貨
USD
テーマ
Kinnate Biopharma Inc. Kinnate Biopharma Inc.

Kinnate Biopharma Inc.

KNTE
株式のランク #21072
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily... Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.
株価
$2.65
最終同期: 2024-04-03
時価総額
$115.71M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Kinnate Biopharma Inc. (KNTE)

カテゴリー

Healthcare
Kinnate Biopharma Inc.（KNTE）の株価履歴
終値の最高値: $2.65 （2024-04-01）

終値の最安値: $40.13 （2020-12-01）
Kinnate Biopharma Inc. の株価履歴（2020 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2024 15.54%
2023 -63.61%
2022 -64.96%
2021 -55.12%
2020 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH